Sa1229 OUTPATIENT TRANSORAL INCISIONLESS FUNDOPLICATION (TIF 2.0) IS SAFE AND EFFECTIVE FOR TREATMENT OF PROVEN GASTROESOPHAGEAL REFLUX DISEASE (GERD) AND LARYNGOPHARYNGEAL REFUX DISEASE (LPRD): A SINGLE CENTER PROSPECTIVE COHORT STUDY